000 04210nam a22004215i 4500
999 _c7423
_d7423
001 7423
003 ES-MaUEC
005 20201203160832.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 190611s2019 si | s |||| 0|eng d
020 _a9789811374586
024 7 _a10.1007/978-981-13-7458-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC257 R3
_b.N83 2019 EB
245 0 0 _aNuclear Medicine in Oncology
_bMolecular Imaging and Target Therapy
_cedited by Gang Huang.
250 _a1st ed. 2019.
264 1 _aSingapore
_bSpringer Singapore :
_bImprint: Springer
_c2019.
300 _a1 recurso en línea (XI, 346 páginas)
_b247 ilustraciones, 157 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _a1. Glucose Metabolism Imaging -- 2. Clinical Utility of 18F-FDG PET/CT in Breast Cancer Management and Targeted Therapy -- 3. The application of 18F-FDG PET/CT in diagnose and therapy of non-small cell lung cancer -- 4. Clinical application of 18F-FDG PET/CT in lymphoma -- 5. Clinical utility of 18F-FDG PET/CT scanning in urological cancers management -- 6. Gynecologic tumor PET / CT imaging -- 7. Molecular imaging and targeted therapy of gastrointestinal cancer -- 8. Head and Neck Cancer -- 9. Molecular imaging and targeted therapy of malignant melanoma -- 10. Role of 18F-FDG PET/CT in Pediatric Oncology -- 11. Molecular imaging -- 12. Receptor targeted radionuclide imaging (RTRI) and peptide receptor radionuclide therapy (PRRT) -- 13. Radioimmunoimaging and targeted therapy -- 14. Apoptosis imaging -- 15. Radionuclide gene and reporter gene imaging -- 16. Na+/I− symporter target for thyroid disease imaging and treatment -- 17. Molecular Imaging and Targeted Therapy In Neurology -- 18. Nuclear cardiolgy -- 19. Equipment for imaging and mechanism, radiation protection -- 20. Molecular imaging probe.
520 _aThis book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.
650 7 _2embne
_9139207
_aOncología
650 7 _2embne
_9139209
_aTumores
700 1 _aHuang, Gang
_eeditor
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789811374579
776 0 8 _iPrinted edition:
_z9789811374593
776 0 8 _iPrinted edition:
_z9789811374609
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-7458-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_zSI